Neuroscience

Global Neuroscience Market 2020 Manufacturer Landscape, Revenue and Volume Analysis and Segment Information up to 2025 The Courier – The Courier

MarketQuest.biz has published a new study on Global Neuroscience Market 2020 by Company, Regions, Type and Application, Forecast to 2025 that delivers a point-by-point analysis of the market covering valuable statistics about market size, status, and growth rate for the forecast period 2021-2026. The report includes a thorough analysis of the latest trends prevalent in this business. The report aims to deliver fundamental data to readers, strategists, senior administration, and advertisers associated with the market. The research discusses key trends that define the industry growth in terms of the regional landscape and competitive outlook. This unique and updated report precisely presents each and every aspect of the global Neuroscience industry and represents it in an easy to understandable format.

Key Insights from the Report:

The report sorts data by segment by type, application, and marketing channel. The report also states the global Neuroscience market scenario by market share, market growth (value and volume). Various important metrics are considered including SWOT analysis of players, all recent developments, upcoming launches, joint ventures, mergers, and accusations of industry-relevant players to know market size forecast and growth estimation.

NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketquest.biz/sample-request/12410

Market Drivers, Limits and Opportunities:

The report also covers industry-oriented drivers, restraints, threats, and opportunities in the global Neuroscience market. The market is deeply evaluated by a current market situation such as market growth factors and constraints. The market propellants, challenges, and threats in the market are further highlighted in the report. In addition, the report offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

The major players profiled in this report include: GE Healthcare, Plexon, Mightex Bioscience, Siemens Healthineers, Tucker-Davis Technologies, Noldus Information Technology, NeuroNexus, Blackrock Microsystems, Thomas RECORDING GmbH, Phoenix Technology Group, Alpha Omega

The most important types covered in this report are: Whole Brain Imaging, Neuro-Microscopy, Electrophysiology Technologies, Neuro-Cellular Manipulation, Stereotaxic Surgeries, Animal Behavior, Other

The most widely used downstream fields of market covered in this report are: Hospitals, Diagnostic Laboratories, Research Institutes, Other

The report explores the current outlook in global and key regions including: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, etc.), Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

ACCESS FULL REPORT: https://www.marketquest.biz/report/12410/global-neuroscience-market-2020-by-company-regions-type-and-application-forecast-to-2025

The Destinations of Statistical surveying Report Are:

The fastest & slowest growing market segments are pointed out in the study to give out significant insights into each core element of the global Neuroscience market. The report describes the market based on the SWOT analysis of every region. The competitive scenario among major players is demonstrated based on their company profile, product introduction, value, gross margin.

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team (sales@marketquest.biz), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: sales@marketquest.bizWeb: http://www.marketquest.biz

View original post here:
Global Neuroscience Market 2020 Manufacturer Landscape, Revenue and Volume Analysis and Segment Information up to 2025 The Courier - The Courier

Neuroscience

Baptist Health Neurologist Addresses the Many Myths of Parkinson’s Disease – Baptist Health South Florida

What do actor Michael J. Fox, rock musician Ozzy Ozbourne and former Miami Heat star Brian Grant all have in common? Theyre just three of the 10 million people worldwide who are living with Parkinsons disease, aneurodegenerative disorder of the brain. Yet, in spite of the number of people who have Parkinsons, there are many misconceptions about the disease.

Sameea Husain Wilson, D.O., is the director of Movement Disorder Neurology at Marcus Neuroscience Institute at Boca Raton Regional Hospital, where she specializes in movement disorders such as Parkinsons disease. She spoke with Resource recently and dispelled some of the most common myths about the disease.

MYTH #1: Everyone with Parkinsons disease has tremors.

FACT: We know this is not true because 30 percent of patients with Parkinsons disease do not experience tremors, says Dr. Husain Wilson. I cant tell you how many patients Ive encountered who said, I didnt think it was Parkinsons because I dont have tremors. They delayed seeing their primary care physician or a neurologist simply because the motor symptoms they were experiencing stiffness, rigidity or balance issues didnt include tremors.

MYTH #2: Aside from medication, there isnt much you can do to treat Parkinsons disease.

FACT: Dr. Husain Wilson says she is saddened by the thought that some people believe this to be true. As patients with Parkinsons learn very quickly when they seek care at Marcus Neuroscience Institute, in addition to medications such as levodopa, there are many other therapies that can help you live with the disease and maintain a good or even great quality of life, she says.

Physical therapy helps patients with their posture, gait, arm swing and cadence, as well as learn how to use their assistive devices such as walkers or canes, according to Dr. Husain Wilson. But it requires commitment from the patient, she adds. You need to practice 30 to 60 minutes a day, every day, with your spouse or an aid who can assist you when needed.

Occupational therapy helps with daily living skills such as feeding, grooming, toileting and bathing, Dr. Husain Wilson says, and speech therapy is extremely beneficial because Parkinsons patients also have problems with voice projection and swallowing. We even address what type of diet they should be eating, given some of the limitations caused by their disease.

Walking and other exercises are extremely beneficial for people living with Parkinsons, as is aqua therapy, according to Dr. Husain Wilson. When patients are walking in water, the buoyancy of the water helps them move in a way that they cannot on land. Riding a stationary bike is also helpful, she says. Yoga and tai chi, too theyre wonderful for reducing rigidity, boosting core strength, maintaining balance and preserving mobility.

MYTH #3: All Parkinsons patients are candidates for High-Intensity Focused Ultrasound (HiFU) therapy.

FACT: There is such a large constellation of symptoms associated with Parkinsons disease, and not all patients have tremors or will develop disabling dyskinesias involuntary uncontrollable movements of one or more parts of the body, particularly the head, arms or legs commonly associated with Parkinsons, says Dr. Husain Wilson. But for patients who do have dyskinesias, she says HiFU can reduce tremors by precisely targeting ultrasound beams through the skull to the thalamus, the pea-sized structure in the brain responsible for transmitting 98 percent of sensory information to the brains cortex, including vision, taste, touch and balance.

With HiFU, we can reduce or eliminate tremors in some patients by using ultrasound beams to destroy lesions in the thalamus that are creating an abnormal circuit in the brain, Dr Husain Wilson says. Its a minimally invasive, image-guided procedure that can be performed painlessly, without anesthesia, while the patient is awake and responsive.

Patients with disabling dyskinesias may also benefit from making thermal lesions in the globus pallidus or subthalamic nucleus, she adds, while a patient with tremors or severe slowness of movement may be treated with thermal lesions in the pallidothalamic tract.

MYTH #4: HiFU is the only surgical treatment option for Parkinsons disease.

FACT: Actually, Deep Brain Stimulation (DBS) surgery has for decades been an effective therapy for many patients with Parkinsons and even today it is used more widely than HiFU, Dr. Husain Wilson says. Patients with advanced Parkinsons also benefit from the Duopa Pump, which is a surgically implanted device that delivers medicine directly to the intestine, where it is readily absorbed. This, she says, reduces the off times during the day that patients experience when taking oral medications to control their disease.

MYTH #5: Parkinsons disease is fatal.

FACT: According to Dr. Husain Wilson, for many patients first diagnosed with Parkinsons disease, the first question they ask is, How long do I have? But people dont die from the disease, she is quick to say they die with the disease.

Parkinsons disease is not fatal, she says. When fatalities do occur, its from complications associated with the disease, such as falls and choking, but not the disease itself. In most cases, Dr. Husain Wilson adds, it was because the patient wasnt following the rules of living with Parkinsons, such as keeping up with physical therapy, strengthening your core, using your assistive device wherever you go, and asking for help when needed. All of these can help prevent falls.

Because choking is also a concern with Parkinsons disease, patients need to be especially careful eating, drinking and taking medications. Eating soft or pureed foods, slowly and deliberately, can help prevent choking, Dr. Husain Wilson says. Also, because swallowing is difficult for people with Parkinsons, many patients find they can keep from aspirating fluids by adding thickeners to beverages and taking medications with applesauce or yogurt.

MYTH #6: Essential Tremor and Parkinsons disease are the same thing.

FACT: Lots of patients think theyre the same thing, because of the tremors, says Dr. Husain Wilson, but as we noted before, not all Parkinsons patients have or develop tremors. People with Parkinsons who do have tremors experience them even when their bodies are at rest, she notes, while those with Essential Tremor get them only when moving their hands and legs.

Neurologists are trained to spot the visible symptoms of Parkinsons disease, Dr. Husain says. Once a clinical diagnosis is made, further confirmation can be made, if needed, with a Dopamine Transporter Scan (DaTscan), which she says allows clinicians to see if your body is manufacturing dopamine properly.

A radioactive tracer is injected into the bloodstream where it eventually attaches to the dopamine transporter molecule on dopamine neurons in the brain, she explains. How those neurons light up under special imaging equipment can confirm whether your dopamine system is healthy or compromised. The scan alone wont make the diagnosis, she emphasizes, but it will help confirm the clinicians diagnosis.

MYTH #7: People with Parkinsons disease shouldnt get the COVID-19 vaccine.

FACT: Not true, says Dr. Husain Wilson. Your movement disorder neurologist is the only person who should be saying whether or not you should get the COVID-19 vaccine, and theyre going to tell you its safe. As a movement disorder neurologist myself, I can tell you that the only reason the vaccine might possibly be an issue was if the patient had an additional medical problem unrelated to their Parkinsons.

Tags: COVID-19 Vaccine, Marcus Neuroscience Institute, movement disorder neurology, movement disorders, Myths about Parkinson's, Parkinson's disease, Sameea Husain Wilson D.O.

View original post here:
Baptist Health Neurologist Addresses the Many Myths of Parkinson's Disease - Baptist Health South Florida

Neuroscience

$15 Million Grant to Renew Center Studying Effects of Maternal Infections on Offspring – UC Davis

Discovering how infections during pregnancy, such as COVID-19 and influenza, can lead to psychiatric illness and developmental disorders in offspring years later, and how to detect, prevent or treat these disorders, is the subject of a $15.7 million grant from the National Institute of Mental Health to the Conte Center at the University of California, Davis.

The UC Davis Conte Center, organized through the Center for Neuroscience, was originally established with an NIH grant in 2016. This grant renews the centers funding for another five years.

UC Davis is in the upper echelon of translational mental health research, said co-principal investigator Cameron Carter, C. Bryan Cameron Presidential Chair in the Center for Neuroscience and distinguished professor of psychiatry and psychology in the School of Medicine. The establishment of a UC Davis Conte Center in 2016 was an incredible accomplishment, and to renew it in 2021 is an even bigger accomplishment.

Building on promising findings from the initial grant, the renewed funding will allow investigators to discover biomarkers for at-risk pregnancies and new treatments to prevent the detrimental effects of maternal infection on brain development in offspring.

The team at the UC Davis Conte Center is helping us understand the origins of significant mental health disorders, said Mark Winey, dean of the College of Biological Sciences. And their research will have far-reaching impacts and provide foundational understandings for how we approach mental health for current and future generations.

Psychiatric illnesses and neurodevelopmental disorders, including schizophrenia, affect 15-20 percent of people worldwide, yet current treatments are at best only partially effective.

The rates of schizophrenia and autism have dramatically increased following pandemics in the past, and we are deeply concerned about a similar impending wave of psychiatric illness following the current COVID-19 pandemic, said co-principal investigator Kimberley McAllister, director of the Center for Neuroscience and a professor in the Department of Neurology, School of Medicine; and Department of Neurobiology, Physiology and Behavior, College of Biological Sciences. Newly funded projects in our center will reveal approaches to mitigate disease in offspring and even to prevent it in future pregnancies.

When an expectant mother is exposed to a pathogen, such as a virus or bacterial infection, her bodys immune response can in some cases trigger neurodevelopmental changes in her offspring. The initial Conte Center grant enabled an interdisciplinary team of researchers to discover that this immune response can result in offspring with changes in brain development and behavior that show up surprisingly early after birth, and that are similar in species as disparate as mice and monkeys.

The changes in brain development and behavior seen in animal models are comparable to changes seen in human neurodevelopmental and psychiatric disorders like schizophrenia and autism.

Most pregnancies, however, are resilient to these risks. The question is how to determine which pregnancies are at risk, and why.

Because many of these diseases start very early in development, often prenatally, we are especially interested in understanding how the immune response of the mother during pregnancy alters brain health in her offspring, McAllister said.

Once these mechanisms are understood, scientists may be able to create novel therapies, treatments and interventions optimized for the developmental age and sex of at-risk offspring following maternal infection, as well as approaches to prevent the effects during at-risk pregnancies.

The purpose of the National Institute of Mental Healths Silvio O. Conte Centers program is to support interdisciplinary teams of researchers addressing high-risk, high-impact questions that will advance our understanding of mental disorders and their treatments. The Conte Center award recognizes the strength of interdisciplinary research at UC Davis, and its researchers together represent a diverse coalition of experts from multiple departments and centers across UC Davis, including the Center for Neuroscience, MIND Institute, Center for Mind and Brain, California National Primate Research Center, College of Biological Sciences, School of Medicine, College of Letters and Science, and College of Engineering.

The Conte Centers NIMH grant renewal is a testament to the groundbreaking, interdisciplinary research that UC Davis School of Medicine and our main campus partners are conducting, said Allison Brashear, dean of the School of Medicine. It is truly impressive to see how UC Davis is bringing together its world-class leaders in neurology, psychiatry, behavioral health and biological sciences, among others, to improve the health of current and future generations.

Read more here:
$15 Million Grant to Renew Center Studying Effects of Maternal Infections on Offspring - UC Davis

Neuroscience

AI Weekly: Continual learning offers a path toward more humanlike AI – VentureBeat

Join GamesBeat Summit 2021 this April 28-29. Register for a free or VIP pass today.

State-of-the-art AI systems are remarkably capable, but they suffer from a key limitation: statisticity. Algorithms are trained once on a dataset and rarely again, making them incapable of learning new information without retraining. This is as opposed to the human brain, which learns constantly, using knowledge gained over time and building on it as it encounters new information. While theres been progress toward bridging the gap, solving the problem of continual learning remains a grand challenge in AI.

This challenge motivated a team of AI and neuroscience researchers to found ContinualAI, a nonprofit organization and open community of continual and lifelong learning enthusiasts. ContinualAI recently announced Avalanche, a library of tools compiled over the course of a year from over 40 contributors to make continual learning research easier and more reproducible. The group also hosts conference-style presentations, sponsors workshops and AI competitions, and maintains a repository of tutorial, code, and guides.

As Vincenzo Lomonaco, cofounding president and assistant professor at the University of Pisa, explains, ContinualAI is one of the largest organizations on a topic its members consider fundamental for the future of AI. Even before the COVID-19 pandemic began, ContinualAI was funded with the idea of pushing the boundaries of science through distributed, open collaboration, he told VentureBeat via email. We provide a comprehensive platform to produce, discuss and share original research in AI. And we do this completely for free, for anyone.

Even highly sophisticated deep learning algorithms can experience catastrophic learning or catastrophic interference, a phenomenon where deep networks fail to recall what theyve learned from a training dataset. The result is that the networks have to be constantly reminded of the knowledge theyve gained or risk becoming stuck with their most recent memories.

OpenAI research scientist Jeff Clune, who helped to cofound Uber AI Labs in 2017, has called catastrophic forgetting the Achilles heel of machine learning and believes that solving it is the fastest path to artificial general intelligence (AGI). Last February, Clune coauthored a paper detailing ANML, an algorithm that managed to learn 600 sequential tasks with minimal catastrophic forgetting by meta-learning solutions to problems instead of manually engineering solutions. Separately, Alphabets DeepMind has published research suggesting that catastrophic forgetting isnt an insurmountable challenge for neural networks. And Facebook is advancing a number of techniques and benchmarks for continual learning, including a model that it claims is effective in preventing the forgetting of task-specific skills.

But while the past several years have seen a resurgence of research into the issue, catastrophic forgetting largely remains unsolved, according to Keiland Cooper, a cofounding member of ContinualAI and a neuroscience research associate at the University of California, Irvine. The potential of continual learning exceeds catastrophic forgetting and begins to touch on more interesting questions of implementing other cognitive learning properties in AI, Cooper told VentureBeat. Transfer learning is one example, where when humans or animals learn something previously, sometimes this learning can be applied to a new context or aid learning in other domains Even more alluring is that continual learning is an attempt to push AI from narrow, savant-like systems to broader, more general ones.

Even if continual learning doesnt yield the sort of AGI depicted science fiction, Cooper notes that there are immediate advantages to it across a range of domains. Cutting-edge models are being trained on increasingly larger datasets in search of better performance, but this training comes at a cost whether waiting weeks for training to finish or the impact of the electricity usage on the environment.

Say you run a certain AI organization that built a natural language model that was trained over weeks on 45 terabytes of data for a few million dollars, Cooper explained. If you want to teach that model something new, well, youd very likely have to start from scratch or risk overwriting what it had already learned, unless you added continual learning additions to the model. Moreover, at some point, the cost to store that data will be exceedingly high for an organization, or even impossible. Beyond this, there are many cases where you can only see the data once and so retraining isnt even an option.

While the blueprint for a continual learning AI system remains elusive, ContinualAI aims to connect researchers and stakeholders interested in the area and support and provide a platform for projects and research. Its grown to over 1,000 members in the three years since its founding.

For me personally, while there has been a renewed interest in continual learning in AI research, the neuroscience of how humans and animals can accomplish these feats is still largely unknown, Cooper said. Id love to see more of an interaction with AI researchers, cognitive scientists, and neuroscientists to communicate and build upon each of their fields ides towards a common goal of understanding one of the most vital aspects of learning and intelligence. I think an organization like ContinualAI is best positioned to do just that, which allows for the sharing of ideas without the boundaries of the academic or industry walls, siloed fields, or distant geolocation.

Beyond the mission of dissemination information about continual learning, Lomonaco believes that ContinualAI has the potential to become a reference points for a more inclusive and collaborative way of doing research in AI. Elite university and private company labs still work mostly behind close doors, [but] we truly believe in inclusion and diversity rather than selective elitiarity. We favor transparency and open-source rather than protective IP licenses. We make sure anyone has access to the learning resources she needs to achieve her potential.

For AI coverage, send news tips to Kyle Wiggers and be sure to subscribe to the AI Weekly newsletterand bookmark our AI channel,The Machine.

Thanks for reading,

Kyle Wiggers

AI Staff Writer

See the rest here:
AI Weekly: Continual learning offers a path toward more humanlike AI - VentureBeat

Neuroscience

Neuroscience Market to Witness Strong Growth Over 2021-2027 | Key Manufacturers Overview- GE Healthcare, Siemens Healthineers, Noldus Information…

The Global Neuroscience Market report dissects the complex fragments of the market in an easy to read manner. This report covers drivers, restraints, challenges, and threats in the Neuroscience market to understand the overall scope of the market in a detailed yet concise manner. Additionally, the market report covers the top-winning strategies implemented by major industry players and technological advancements that steers the growth of the market.

Key Players Landscape in the Neuroscience Report

GE HealthcareSiemens HealthineersNoldus Information TechnologyMightex BioscienceThomas RECORDING GmbHBlackrock MicrosystemsTucker-Davis TechnologiesPlexonPhoenix Technology GroupNeuroNexusAlpha OmegaNeuroscienc

Note: Additional or any specific company of the market can be added in the list at no extra cost.

Here below are some of the details that are included in the competitive landscape part of the market report:

This market research report enlists the governments and regulations that can provide remunerative opportunities and even create pitfalls for the Neuroscience market. The report confers details on the supply & demand scenario in the market while covering details about the product pricing factors, trends, and profit margins that helps a business/company to make crucial business decisions such as engaging in creative strategies, product development, mergers, collaborations, partnerships, and agreements to expand the market share of the company.

Get Free Exclusive Sample report @ https://industrygrowthinsights.com/request-sample/?reportId=168030

An Episode of Impact of COVID-19 Pandemic in the Neuroscience Market

The COVID-19 pandemic had disrupted the global economy. This is due to the fact that the government bodies had imposed lockdown on commercial and industrial spaces. However, the market is anticipated to recover soon and is anticipated to reach the pre-COVID level by the end of 2021 if no further lockdown is imposed across the globe.

In this chapter of the report, Industry Growth Insights (IGI) has provided in-depth insights on the impact of COVID-19 on the market. This chapter covers the long-term challenges ought to be faced due to the pandemic while highlights the explored opportunities that benefited the industry players globally. The market research report confers details about the strategies implemented by industry players to survive the pandemic. Meanwhile, it also provides details on the creative strategies that companies implemented to benefit out of pandemic. Furthermore, it lays out information about the technological advancements that were carried out during the pandemic to combat the situation.

What are the prime fragments of the market report?

The Neuroscience report can be segmented into products, applications, and regions. Here below are the details that are going to get covered in the report:

Products

Whole Brain ImagingNeuro-MicroscopyElectrophysiology TechnologiesNeuro-Cellular ManipulationStereotaxic SurgeriesAnimal BehaviorOtherWhole Brain Imaging, Neuro-Microscopy, and Electrophysiology Technologies are the top three types of neuroscience, with a combined market share of 62%Neuroscienc

Applications

HospitalsDiagnostic LaboratoriesResearch InstitutesOtherNeuroscience is applied mostly in the hospital with a market share of 47%. It is followed by Research Institutes and Diagnostic Laboratories

Regions

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America

Note: A country of your own choice can be added to the list at no extra cost. If more than one country needs to be added, the research quote varies accordingly.

Buy the complete report in PDF format: https://industrygrowthinsights.com/checkout/?reportId=168030

Below is the TOC of the report:

Executive Summary

Assumptions and Acronyms Used

Research Methodology

Neuroscience Market Overview

Global Neuroscience Market Analysis and Forecast by Type

Global Neuroscience Market Analysis and Forecast by Application

Global Neuroscience Market Analysis and Forecast by Sales Channel

Global Neuroscience Market Analysis and Forecast by Region

North America Neuroscience Market Analysis and Forecast

Latin America Neuroscience Market Analysis and Forecast

Europe Neuroscience Market Analysis and Forecast

Asia Pacific Neuroscience Market Analysis and Forecast

Asia Pacific Neuroscience Market Size and Volume Forecast by Application

Middle East & Africa Neuroscience Market Analysis and Forecast

Competition Landscape

If you have any doubt about the report, please feel free to contact us @ https://industrygrowthinsights.com/enquiry-before-buying/?reportId=168030

About Industry Growth Insights (IGI)

Industry Growth Insights (IGI) has extensive experience in the creation of tailored market research reports in several industry verticals. We cover in-depth market analysis which includes producing creative business strategies for the new entrants and the emerging players of the market. We take care that our every report goes through intensive primary, secondary research, interviews, and consumer surveys. Our company provides market threat analysis, market opportunity analysis, and deep insights into the current and market scenario.

To provide the utmost quality of the report, we invest in analysts that hold stellar experience in the business domain and have excellent analytical and communication skills. Our dedicated team goes through quarterly training which helps them to acknowledge the latest industry practices and to serve the clients with the foremost consumer experience.

Contact Info: Name: Alex MathewsAddress: 500 East E Street, Ontario,CA 91764, United States.Phone No: USA: +1 909 414 1393Email: [emailprotected]Website: https://industrygrowthinsights.com

Read this article:
Neuroscience Market to Witness Strong Growth Over 2021-2027 | Key Manufacturers Overview- GE Healthcare, Siemens Healthineers, Noldus Information...

Neuroscience

University of Eastern Finland wins 1.5M EU grant for Neuro- Innovation PhD programme – Science Business

The University of Eastern Finland has received EU funding to recruit 14 doctoral students into a four-year multidisciplinary Neuro-Innovation PhD programme, which will be implemented on the Kuopio campus.

The Marie Skodowska-Curie Cofund grant of 1,5 million euros will increase the scope and quality of multidisciplinary research in the UEF Neuroscience Research Community (NEURO). Thereby, it will also generate a strong positive impact on health innovation in Finland and beyond.

The recruitment of the international PhD students will start in June 2021.

Neuro-Innovation PhD programme is one of the key milestones in our strategy to promote the integration of biological neuroscience with innovation management, data science as well as ethics and law. Importantly, this programme challenges research groups to expand their research and training towards crossdisciplinarity beyond the conventional, ProfessorMikko Hiltunen, Director of NEURO, says.

Broad collaboration

The doctoral programme will be implemented in the Faculty of Health Sciences, the Faculty of Social Sciences and Business Studies, and the Faculty of Science and Forestry at the University of Eastern Finland.

Researchers from neurosciences, management, legal, social and data sciences and applied physics will educate innovation leaders with novel competences to create ethical and sustainable solutions to advance brain health throughout the life.

The world-class partner universities offer students opportunities to pay shorter and longer visits with them, and learn about international research practices and career paths.

Stakeholder interaction

During their studies, the PhD students will learn about, not only multidisciplinary academic research, but also university-society interaction.

The doctoral program engages partner stakeholders, such as the Kuopio University Hospital (KUH), innovation and health ecosystems, patient organizations and health companies, to work with PhD students and their supervisors.

This new education will create a strongly demanded and highly beneficial talent hub of brain health innovation in the Kuopio region.

Strengthening the work life integration of doctoral education is very important for the University of Eastern Finland. The collaboration that will be implemented with this grant can provide us a model for the re-development of our existing doctoral programmes, Academic RectorTapio Mttacknowledges.

New career paths

Intensive career coaching of the PhD students is a special feature of the Neuro-Innovation PhD programme.

The graduates will have unique combinations of academic and practical skills needed in future jobs and cross-sectoral career paths.

The students will develop excellent abilities to operate as multi-talented innovation agents in science, business and policy.

"The ability to combine research on neuroscience with law and ethics, business or data sciences gives the students an entirely new perspective on the impact their research can make to the society. This will also significantly boost the cross-disciplinary collaboration within UEF and internationally", ProfessorTarja Malm, Co-coordinator of the Neuro-Innovation programme, says.

We warmly welcome international applicants who wish to advance brain health innovation for the benefit of patients and their families, ProfessorPivi Eriksson, Coordinator of the Neuro-Innovation PhD programme, encourages.

Information about the Neuro-Innovation PhD programme on websitewww.uef.fi/neuro-innovation.

View post:
University of Eastern Finland wins 1.5M EU grant for Neuro- Innovation PhD programme - Science Business

Neuroscience

Close to Three Dozen Indian American Young Researchers Named 2021 Barry Goldwater Scholars – India West

The Barry Goldwater Scholarship & Excellence in Education Foundation recently announced its 2021 class of Goldwater Scholars, with close to at least three dozen Indian Americans among the group.

Peggy Goldwater Clay, chair of the board of trustees of the foundation, announced the names of the scholars, noting that the trustees of the Goldwater Board have increased the number of Goldwater scholarships it has awarded for the 2021-2022 academic year to 410 college students as a result of its partnership with the Department of Defense National Defense Education Programs.

As it is vitally important that the nation ensures that it has the scientific talent it needs to maintain its global competitiveness and security, we saw partnering with the Goldwater Foundation as a way to help ensure the U.S. is developing this talent, said Dr. Jagadeesh Pamulapati, Indian American director of the NDEP program, as he explained the partnership.

Many of the scholars have published their research in leading professional journals and have presented their work at professional society conferences, a news release said, adding that Goldwater Scholars have impressive academic and research credentials that have garnered the attention of prestigious post-graduate fellowship programs.

Among the Indian American 2021 scholars named were:

Aaditya Rau of Johns Hopkins University

Field of Study: Engineering

Career Goal: Ph.D. in mechanical engineering; to conduct research in modeling of the synthesis and processing of advanced materials at an academic institution.

Karthik Reddy of the University of Alabama at Birmingham

Field of Study: Psychology

Career Goal: Ph.D. in cognitive neuroscience; to investigate the neural mechanisms involved in memory and learning impairments experienced by children with complex medical conditions.

Aditi Gnanasekar of the University of California-San Diego

Field of Study: Engineering

Career Goal: M.D./Ph.D. in computational medicine; treat patients and lead own research group to develop more effective and affordable cancer diagnostic and treatment technologies.

Pratyush Muthukumar of the University of California-Irvine

Field of Study: CISE

Career Goal: Ph.D. in machine learning; research and develop ethical and effective machine learning models that increase interconnectivity and altruism among people, especially in the healthcare setting.

Seema Patel of the University of Connecticut

Field of Study: Life Sciences

Career Goal: M.D./Ph.D. in pharmacology; conduct basic and translational research in oncology, specifically developing novel anti-cancer drugs, and teach at the medical/graduate school level.

Sidhika Balachandar from Stanford University

Field of Study: CISE

Career Goal: Ph.D. in computer science and become a professor to teach and conduct research in the use of artificial intelligence for computational biology.

Shovan Bhatia from Georgia Institute of Technology-Main Campus

Field of Study: Engineering

Career Goal: M.D./Ph.D. in neuroengineering and combining novel engineering-based strategies to improve the functional independence and quality of life of people living with neurological impairments.

Tejas Athni of Stanford University

Field of Study: Life Sciences

Career Goal: M.D.-Ph.D.; conduct research on the molecular mechanisms and eco-epidemiological drivers of disease, lead an interdisciplinary research group, and mentor the next generation of scientists.

Chetna Batra from Georgia State University

Field of Study: Life Sciences

Career Goal: M.D./Ph.D. in microbiology; conduct research on the intersection between microbiology and public health. Applying medical knowledge to study lipid-related diseases at the cellular level.

Geetika Patwardhan from the University of Hawaii at Manoa

Field of Study: Life Sciences

Career Goal: M.D./Ph.D. in cellular and molecular biology; conduct research as a physician-scientist in Hawaii.

Ashma Pandya from the University of Illinois at Chicago

Field of Study: Chemistry

Career Goal: Ph.D. in biophysics; study the transition from physiochemical to biological systems, first at a national lab and then at a university.

Sanketh Andhavarapu from the University of Maryland-College Park

Field of Study: Life Sciences

Career Goal: MD/Ph.D. in neuroscience; conduct laboratory and translational research to formulate therapies for neurological diseases using insights from my clinical practice at an academic medical institution.

Naveen Durvasula from the University of California-Berkeley

Field of Study: CISE

Career Goal: Ph.D. in computer science, specializing in theory and artificial intelligence; develop tools with the potential to impact many as a professor of computer science.

Karan Luthria from the University of Maryland-Baltimore County

Field of Study: CISE

Career Goal: Ph.D. in computational biology; aspire to lead a research team in developing computational tools to improve our understanding, diagnosis and treatment of human diseases.

Naveen Raman from the University of Maryland-College Park

Field of Study: CISE

Career Goal: Ph.D. in computer science and become a professor and research the fairness of artificial intelligence algorithms in critical fields such as criminal justice, job markets, and health care.

Anjini Chandra from the California Institute of Technology

Field of Study: Engineering

Career Goal: Ph.D. in mechanical engineering and later conduct research in fluid mechanics and teach at the university level.

Karthik Ravi of the University of Michigan-Ann Arbor

Field of Study: Life Sciences

Career Goal: M.D./Ph.D.; work as a research scientist in the field of pediatric neuro-oncology at an academic research institution.

Pushya Krishna from Montana State University

Field of Study: Life Sciences

Career Goal: M.D./Ph.D. in neuroscience; conduct research on neurodegenerative disorders and to develop new clinical therapies to improve patient outcomes.

Joheen Chakraborty from Columbia University in the City of New York

Field of Study: Physics and Astronomy

Career Goal: Pursue research at the intersection of computing and astrophysics, using computational tools to assist with analysis of massive datasets and numerical simulations of complex physical systems.

Harshini Raman from Wellesley College

Field of Study: Medicine

Career Goal: Ph.D. in neuroscience; M.D., specialization in psychiatry and conduct research in neuroscience and teach at a university hospital.

Sreya Sanyal from New Jersey Institute of Technology

Field of Study: Life Sciences

Career Goal: M.D./Ph.D. in cancer biology; conduct translational research that optimizes and delivers novel cancer therapeutics and to teach at the graduate level.

Kevan Shah of Muhlenberg College

Field of Study: Life Sciences

Career Goal: Ph.D. in neuroscience; conduct research on the underpinnings of memory and their implications for Alzheimers dementia and related diseases.

Anoop Kiran from the University at Buffalo

Field of Study: Engineering

Career Goal: Ph.D. in aerospace engineering, focused on aerodynamics and fluids; to improve existing flight dynamics capabilities by serving at a national lab.

Ishaan Madan from Wheaton College

Field of Study: Chemistry

Career Goal: Ph.D. in organic chemistry; conduct research in astrobiology and collaborate in space exploration missions for ocean world environments aiming to understand the emergence of precursors of life.

Arvind Mahankali from Carnegie Mellon University

Field of Study: CISE

Career Goal: Ph.D. in computer science, focusing on algorithms and machine learning and teach and conduct research in these topics at the university level.

Tara Venkatadri from Massachusetts Institute of Technology

Field of Study: Engineering

Career Goal: Ph.D. in aerospace engineering; conduct research that advances the field of space exploration and helps humanity travel to and learn more about the planets around us.

Sanjeeth Rajaram from the University of Cincinnati-Main Campus

Field of Study: Medicine

Career Goal: M.D./Ph.D. in immunology; conduct basic/translational research on autoimmunity at a collaborative academic medical center to create therapies for immunological disease.

Shiker Nair of Johns Hopkins University

Field of Study: Engineering

Career Goal: M.D./Ph.D. in biomedical engineering; lead a research team specializing in applying bioinformatics and computational biology to precision medicine.

Pradyot Yadav from Georgia Institute of Technology-Main Campus

Field of Study: Engineering

Career Goal: Ph.D. in microwave engineering; working as a technical fellow at a semiconductor company conducting research on advanced III-V compound semiconductors and novel RF topologies.

Sai Sarnala from the University of North Texas

Field of Study: Life Sciences

Career Goal: Ph.D. in plant genetics; develop transgenic plant lines to provide novel methods for pharmaceutical development and disease prevention.

Saket Bikmal of Virginia Polytechnic Institute and State University

Field of Study: Life Sciences

Career Goal: MD/Ph.D. specializing in neural engineering and computational neuroscience; conduct medical device research, particularly focusing on neuro-assistive technologies for special needs children.

Anish Karpurapu from Duke University

Field of Study: Life Sciences

See the rest here:
Close to Three Dozen Indian American Young Researchers Named 2021 Barry Goldwater Scholars - India West

Neuroscience

The path to deeper connections, even amidst a pandemic | Penn Today – Penn Today

For the past year, staying physically apart from others was crucial to keeping everyone safe in the face of a brand new, deadly virus. Though necessary, the social distancing also amplified an already troubling fact: Rates of loneliness have been rising for the past several decades in the United States.

Even before the pandemic, the increase in loneliness has been striking, says Edward Brodkin, a psychiatrist in Penns Perelman School of Medicine. And then along comes the pandemic, which of course separated us even more.

That separation made everyday communication and interaction challenging, says Ashley Pallathra, a clinical psychology doctoral candidate at The Catholic University of America and a former member of Brodkins lab. In person, wearing masks covers our ability to communicate through facial expressions, she says. And from the quarantining and isolation, people started to feel the loss of intimate, close relationships but also the loss of people on the commute to work or in the local coffee shop.

In their new book, Missing Each Other: How to Cultivate Meaningful Connections, Brodkin and Pallathra explore the science of attunement, the process necessary for relationships to move beyond the surface level to deeper and sometimes more emotional connections.

Broadly speaking, attunement describes an awareness thats both internal and external facing, of ones own state of mind and body and that of another person. Attunement involves an ability to get in sync with others, to engage with them effectively, not just in a single moment but over an interactions twists and turns.

It shows up in many aspects of life beyond personal relationships, for example, in team sports or music ensembles. Although its obviously most important in close relationships, it can also be helpful in our day-to-day interactions, Brodkin says. We could communicate better so were not talking past each other.

To elucidate this intricate process of connection, Brodkin and Pallathra propose a framework for understanding attunement, which they argue consists of four components: relaxed awareness, listening, understanding, and mutual responsiveness. They offer exercises for readers to develop each skill.

The idea for the book grew out of work from Brodkins lab, which focuses on autism, social neuroscience, and how the brain functions in social interactions. He and Pallathra were collaborating on a project aimed at supporting adults on the autism spectrum in their social functioning. The further into it they got, the more they realized they wanted their project to go beyond traditional social skills.

That type of program often includes suggested social scripts and rules, which can be useful sometimes, but they are also limited, Brodkin says. It dawned on us that we were really trying to teach attunement. Then we thought, maybe this program is not only useful for adults on the autism spectrum. Maybe it could be helpful for any of us. Its a difficult skill but one that, if you understand and develop it, can have a huge payoff.

Missing Each Other lays out the four components of attunement sequentially, with each one building on the last:

This means being aware of yourself as well as your environment, being aware of how you feel, your emotions, your reactions, but also aware of whats going on around you, of the conversation youre having, of the message another person is trying to communicate, all while staying fairly relaxed, Pallathra says. She describes it as a type of mindfulness involving awareness and emotional self-regulation, rather than a focus on emptying the mind.

This second step isnt just about hearing the words another person is saying, but broader, taking in all social cues from the pacing and tone of speech to body language and facial expression. Its about paying attention and synchronythe subconscious mirroring that takes place in a conversation, like when one person nods or crosses his legs after the other does. Its also about resonating with the other person emotionally, in other words, having emotional empathy.

This entails understanding another persons perspective but also your own, Pallathra says. There are a lot of pitfalls to understanding, things that get in the way like your biases and assumptions, your reactivity. Being able to recognize those will help create a balance between regulating yourself and staying open to the other person.

This is the natural back and forth of a lively and fulfilling conversation or interaction. Partners meet in the middle, responding to each others moods. Its paradoxical to think of meeting the other person where they are as a way of being powerful and getting your message across, Brodkin says. But if you cultivate this art of being open to the other person, listening, understanding, and initiating a connection where the other person is mentally and emotionally, youre in a better position to communicate what you want to communicate, too.

Brodkin and Pallathra offer a set of exercises that may help enhance each skill. For instance, stretches to release physical tension and mindfulness of posture and breath can help develop relaxed awareness. For listening, they suggest motor synchrony exercises based on tai chi or a simple how-was-your-day conversation.

Ask someone to tell you about their day, Brodkin explains. Then for three to five minutes, really try to listen. Give the other person an opportunity to talk. Focus on what shes communicating and occasionally check back with yourself. Take a breath to regulate yourself and then refocus on the other person. Practice regularly and you can develop this capacity, much like you develop your biceps at the gym.

All of these exercises can be adapted for at-home use, he adds. Develop these on your own or with people in your social bubble, so when we do come back together, well be better communicators.

Edward Brodkin is co-director of the Autism Spectrum Program of Excellence at the University of Pennsylvania. He is also founder and director of the Adult Autism Spectrum Program and an associate professor of psychiatry at the Perelman School of Medicine.

Ashley Pallathra is a clinical researcher and therapist and is currently pursuing her Ph.D. in clinical psychology at The Catholic University of America in Washington, D.C. She is a Penn alumna and former member of the Brodkin lab.

Read the original:
The path to deeper connections, even amidst a pandemic | Penn Today - Penn Today

Neuroscience

Blumberg to Speak on Teen Suicide Prevention Panel – Yale School of Medicine

Hilary Blumberg, MD, John and Hope Furth Professor of Psychiatric Neuroscience and Professor of Psychiatry, and in the Child Study Center and of Radiology and Biomedical Imaging, will participate in a panel discussion Sunday, April 11, 2021, related to the prevention of youth suicide.

The panel will follow the screening of the documentary My Ascension, a feature-length film that chronicles the experience of Emma Benoit, a then-16-year-old cheerleader who survived a suicide attempt in 2017 the summer before her senior year in high school. Her attempt resulted in a spinal cord injury that left her paralyzed but also helped her find faith and purpose and put her on a mission to help prevent youth suicide.

The film also highlights the stories of two young people who did not survive their suicide attempts. Viewers will hear from their families, friends, school officials, and suicide prevention experts about the devastating effects of suicide and what can be done to prevent it.

The movie and panel discussion will be from 6:00 to 9:00 pm April 11. Registration is free.

The panel will be moderated by Gregg Dicharry, director of My Ascension. In addition to Blumberg it will feature Benoit; actress Jessica Hecht, Olympic gold medalist Samantha Livingstone, and Gillian Anderson, founder of My Friend Abby, the events host.

Anderson created My Friend Abby after the death of her 15-year-old daughter, Abby, by suicide. The non-profit organizations mission is to empower youth and young adults to actively create peer to peer connections through grants that improve mental and emotional health.

Blumberg directs the Mood Disorders Research Program at Yale. The organization brings together a multi-disciplinary group of scientists to study the genetic, developmental, and environmental factors that cause mood disorders to develop new methods for early detection, more effective interventions, and prevention of the disorders and their associated high risk for suicide. This research includes the use of new state-of-the-art brain scanning methods. The program trains young scientists to be new leaders in the field.

Read this article:
Blumberg to Speak on Teen Suicide Prevention Panel - Yale School of Medicine

Immunology

Genomic testing services in pathology & immunology department to be expanded Washington University School of Medicine in St. Louis – Washington…

Visit the News Hub

Changes aimed at improving diagnosis of cancer, inherited diseases

The Department of Pathology & Immunology at Washington University School of Medicine in St. Louis is reorganizing and expanding its genomic medicine testing services to take advantage of advances in genetic and genomic sciences and improve clinical care.

Genetic and genomic testing is driving advances in precision medicine. Such testing provides the data that, when combined with information about disease status and environmental factors, enable doctors to move away from one-size-fits-all treatment plans to personalized therapies tailored to individual needs.

The Department of Pathology & Immunology at Washington University School of Medicine in St. Louis is reorganizing and expanding its genomic medicine testing services to take advantage of advances in genetic and genomic sciences and improve clinical care. Several new tests for cancer and inherited diseases are in the works. The department also is redesigning its website to make it easier for physicians to quickly identify the most appropriate tests for their patients.

As part of the reorganization, the department is establishing two new sections: a molecular oncology section, led by Eric Duncavage, MD, and an inherited diseases section, headed by Jonathan Heusel, MD, PhD.

The School of Medicine has been at the forefront of genetics research for many years, including leadership in whole genome sequencing, saidRichard Cote, MD, the Edward Mallinckrodt Professor and head of the Department of Pathology & Immunology. We have long had a major stake in translating these discoveries into clinically actionable tests to better define prognosis and treatment for a wide variety of diseases. We are delighted that Jon Heusel and Eric Duncavage, widely recognized for their research, are leading the effort to enhance the departments genetic and genomic testing services.

A wide variety of different mutations can give rise to cancer, and the specific mutations carried by a particular tumor affect its susceptibility to a particular treatment. These mutations also can be used to track a tumor during therapy to determine how it is responding to therapy. Clinical cancer genomics aims to use information on tumor mutations to help identify the therapies most likely to benefit the patient and avoid those least likely to help.

Duncavage

Duncavage and his Washington University colleagues recently developed a diagnostic test, ChromoSeq, for blood cancers, based on sequencing the whole genome. This comprehensive analysis has greater sensitivity than traditional testing, providing additional information that could help clinicians assess each patients risk of severe disease and choose the best treatment plan. The test was evaluated in a clinical trial of patients treated at Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine. Results of that trial were published in March in The New England Journal of Medicine. ChromoSeq whole genome sequencing for blood cancers will be available as a clinical test through the Department of Pathology & Immunology.

Until recently, we could only analyze a limited set of genes or chromosomes because whole genome sequencing was too expensive for routine clinical use, Duncavage said. But recent advances in sequencing technologies and data analysis techniques have driven down the cost of whole genome sequencing in both time and resources. We showed that the technology could be used for blood cancers, and we are working on applying it to other kinds of cancers.

In addition, Heusel and Duncavage are spearheading an effort to develop tests to identify people with an inherited predisposition to cancer. Most famously, variations in the BRCA1 and BRCA2 genes increase the risk of breast and ovarian cancer, but dozens of other genes have been linked to a range of cancers. In the interest of efficiency, the tests under development are based on sequencing only the 2% of the genome that codes for proteins. This tiny fraction of the genome known as the exome is where nearly all mutations associated with disease risk are found.

Heusel

As chief of the inherited diseases section, Heusel will oversee the development and operation of tests for rare genetic diseases. Some of the people most in need of whole genome testing are babies born with mysterious ailments that appear to have genetic causes. Sequencing an affected newborns entire genome and often the genomes of both parents, too can be the fastest way to find an explanation for a babys condition.

Heusel and colleagues also are working on an improved test for disorders of somatic mosaicism, a group of conditions characterized by mutations in some cells but not others. Patients can have a wide range of symptoms, including overgrowth of one part of the body, such as the hand; skin spots or rashes; and abnormal tangles of blood vessels. The symptoms depend not only on what mutation has occurred but in which cells it has occurred. The researchers are building a faster, cheaper test that will allow more genes and more conditions to be screened.

Genetic testing particularly what we call next-generation sequencing, which involves sequencing dozens or hundreds of genes or whole exomes or whole genomes its transforming medicine, transforming the way we understand the basis of disease, how to diagnose it and how to treat it, Heusel said. What were really trying to do in the department now is make it easier for clinicians to take advantage of all the new genetic and genomic diagnostic tools that are becoming available.

Washington University School of Medicines 1,500 faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Childrens hospitals. The School of Medicine is a leader in medical research, teaching and patient care, consistently ranking among the top medical schools in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Childrens hospitals, the School of Medicine is linked to BJC HealthCare.

Link:
Genomic testing services in pathology & immunology department to be expanded Washington University School of Medicine in St. Louis - Washington...